|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/55 | (2006.01) |
| A61P 9/00 | (2006.01) |
| (11) | Number of the document | 1695710 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06290329.9 |
| Date of filing the European patent application | 2006-02-28 | |
| (97) | Date of publication of the European application | 2006-08-30 |
| (45) | Date of publication and mention of the grant of the patent | 2008-06-04 |
| (46) | Date of publication of the claims translation | 2008-09-25 |
| (30) | Number | Date | Country code |
| 0501987 | 2005-02-28 | FR |
| (72) |
Horvath, Stéphane, FR
Auguste, Marie-Noelle, FR
Damien, Gérard, FR
|
| (73) |
Les Laboratoires Servier,
12, Place de La Défense, 92415 Courbevoie Cedex,
FR
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Ivabradino hidrochlorido beta-d-kristalinė forma, jos gavimo būdas ir ją turinčios farmacinės kompozicijos |
| Crystalline form beta-d of the chlorohydrate of ivabradine, process for its preparation and pharmaceutical compositions containing it |
| Payment date | Validity (years) | Amount | |
| 2025-01-21 | 20 | 347.00 EUR |